Sensorion announces an oral presentation at the 5th congress of European ORL-Head & Neck Surgery in Brussels. pdfRead

Sensorion receives European Medicines Agency agreement on the Pediatric Investigation Plan (PIP) for Arazasetron  (SENS-401) in two indications. pdfRead

Sensorion announces that the “AUDINNOVE” project of which Sensorion is a partner is a laureate of the fourth solicitation request for funding from RHU as part of the French “Avenir investment program”. pdfRead

Sensorion announces a €20m convertible bond issue subscribed by two renowned investors Invus and Sofinnova Partners. pdfRead

Sensorion Announces Poster Presentation at the “Société Internationale d’Otoneurologie” Symposium. pdfRead


20190603 pipeline


Patient center

Corporate presentation

Next events